Dariusz Gorecki

Academic, Professor, Professor of Molecular Medicine

University of Portsmouth

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Robin Mark Howard Rumney

University of Southampton

UNITED KINGDOM

View details

Annalisa Occhipinti

Teesside University

UNITED KINGDOM

View details

Michal Korostynski

Institute of Pharmacology

POLAND

View details

Jerome Swinny

Academic, Professor, Professor of Neuropharmacology

University of Portsmouth

UNITED KINGDOM

View details

Matthew Guille

Academic, Professor, Professor of Developmental Genetics

University of Portsmouth

UNITED KINGDOM

View details

Claudio Angione

Professor

Teesside University

UNITED KINGDOM

View details

Mohsen Seifi

Senior Lecturer in Pharmacology

De Montfort University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dariusz Gorecki

Research Interests

Explore related searches

Contact this professor

Articles (13)

Investigating the Involvement of C−X−C Motif Chemokine 5 and P2X7 Purinoceptor in Ectopic Calcification in Mouse Models of Duchenne Muscular Dystrophy

The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia

Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas

Primary mouse myoblast metabotropic purinoceptor profiles and calcium signalling differ with their muscle origin and are altered in mdx dystrophinopathy

The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies

The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies

Automated multi‐sample DNA extraction for genotyping live Xenopus embryos

Downregulation of Dystrophin Expression Occurs across Diverse Tumors, Correlates with the Age of Onset, Staging and Reduced Survival of Patients

Specific dystrophins selectively associate with inhibitory and excitatory synapses of the mouse cerebellum and their loss alters expression of P2X7 purinoceptors and pro-inflammatory mediators

Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD

Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts

α-Dystrobrevin knockout mice have increased motivation for appetitive reward and altered brain cannabinoid receptor 1 expression

P2X7 Purinoceptor Affects Ectopic Calcification of Dystrophic Muscles

Collaborators (7)

Robin Mark Howard Rumney

Annalisa Occhipinti

Michal Korostynski

Jerome Swinny

Matthew Guille

Claudio Angione

Mohsen Seifi

Make your next move.